Medical Research
(H30Z)
990 on File
THE RICBAC FOUNDATION
Financial strength (30%)
91/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$2.6M
Total Revenue
$2.1M
Total Expenses
$42.1M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
86.2%
Fundraising Efficiency
N/A
Operating Reserve
235.86x
Liability-to-Asset
0.3%
Revenue Diversification
89.7%
Executive Compensation
$100K
Compared with Peers
FY 2023
Compared with 479 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
86.2% | 82.4% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
235.9 mo | 14.9 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.3% | 11.5% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
89.7% | 93.1% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
36.5% | 7.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-48.4% | 12.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
16.2% | 0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.6M | $2.1M | $42.1M | 86.2% | — |
| 2022 | $1.9M | $4.2M | $41.7M | 93.7% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.